Response: The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptic drugs: Comment on data sparsity

Epilepsia. 2018 May;59(5):1084-1085. doi: 10.1111/epi.14063.

Noel Frey^{1

2}, Michael Bodmer³, Andreas Bircher⁴, Stephan Rüegg⁵, Susan S Jick⁶, Christoph R Meier^{1

2

6}, Julia Spoendlin^{1

2}

¹ Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.
² Hospital Pharmacy, University Hospital Basel, Basel, Switzerland.
³ Internal Medicine, Cantonal Hospital Zug, Basel, Switzerland.
⁴ Allergology, University Hospital Basel, Basel, Switzerland.
⁵ Division of Clinical Neurophysiology, University Hospital Basel, Basel, Switzerland.
⁶ Boston Collaborative Drug Surveillance Program, Boston University, Lexington, MA, USA.

No abstract available

Publication types